about
Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effectsBmTx3, a scorpion toxin with two putative functional faces separately active on A-type K+ and HERG currentsKv2 subunits underlie slowly inactivating potassium current in rat neocortical pyramidal neuronsPeptide toxins and small-molecule blockers of BK channelsNeuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and PitfallsCentipede venoms and their components: resources for potential therapeutic applicationsScorpion toxins specific for potassium (K+) channels: a historical overview of peptide bioengineeringGeneral Sensitization of melanoma cells for TRAIL-induced apoptosis by the potassium channel inhibitor TRAM-34 depends on release of SMACRole of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injuryAMIGO is an auxiliary subunit of the Kv2.1 potassium channelA thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells.Variations in potassium channel genes are associated with breast pain in women prior to breast cancer surgery.Computational simulations of interactions of scorpion toxins with the voltage-gated potassium ion channel.HIV-1 Tat protein increases microglial outward K(+) current and resultant neurotoxic activity.Involvement of Kv1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity.Hydrogen sulfide preconditioning or neutrophil depletion attenuates ischemia-reperfusion-induced mitochondrial dysfunction in rat small intestine.Determinants of voltage-gated potassium channel surface expression and localization in Mammalian neurons.Effects of fluoxetine on protein expression of potassium ion channels in the brain of chronic mild stress rats.Potassium channels as targets for therapeutic intervention.Fampridine-SR for multiple sclerosis and spinal cord injury.S3b amino acid substitutions and ancillary subunits alter the affinity of Heteropoda venatoria toxin 2 for Kv4.3.Advances in functional assays for high-throughput screening of ion channels targets.The voltage-dependent K(+) channels Kv1.3 and Kv1.5 in human cancer.Ion channels and osteoarthritic pain: potential for novel analgesics.The Cdc42 inhibitor secramine B prevents cAMP-induced K+ conductance in intestinal epithelial cells.Purification, molecular cloning and functional characterization of HelaTx1 (Heterometrus laoticus): the first member of a new κ-KTX subfamilySelective intermediate-/small-conductance calcium-activated potassium channel (KCNN4) blockers are potent and effective therapeutics in experimental brain oedema and traumatic brain injury caused by acute subdural haematoma.BmBKTx1, a novel Ca2+-activated K+ channel blocker purified from the Asian scorpion Buthus martensi Karsch.Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation.Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells.Involvement of KATP and KvLQT1 K+ channels in EGF-stimulated alveolar epithelial cell repair processes.Cell-based fluorescence screen for K+ channels and transporters using an extracellular triazacryptand-based K+ sensor.Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice.Electrophysiological characterization of a novel Kv channel blocker N,N'-[oxybis(2,1-ethanediyloxy-2,1-ethanediyl) ]bis(4-methyl)-benzenesulfonamide found in virtual screening.Association between connexin 40 and potassium voltage-gated channel subfamily A member 5 expression in the atrial myocytes of patients with atrial fibrillation.Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effects of gabapentin in mouse forced swimming test.Novel genetically encoded fluorescent probes enable real-time detection of potassium in vitro and in vivo.Differential expression of a novel voltage gated potassium channel--Kv 1.5 in astrocytomas and its impact on prognosis in glioblastoma.Aptamer-based FRET nanoflares for imaging potassium ions in living cells.Synthesis, Characterization, and Antihypertensive Evaluation of Some Novel 2,2,8,8-Tetramethyl-2,3,7,8-tetrahydro-4,6-diamino-3,7-dihydroxy-6,7-epoxy-benzo-[1,2-b:5,4-b′]dipyran Derivatives
P2860
Q21091199-9C6D724D-D9DA-4EBF-835F-34BF9E4A0677Q24530692-081477BF-C0E3-4CB0-B638-6F0120B967C0Q24679678-D579A23A-06AF-467F-A988-EB8DDD717A4BQ26771356-8BF9477C-428D-416F-AC28-9C4CE344F1C6Q26798018-7D05950A-BC97-49EC-92D4-F26C57E33A3DQ26825574-5605757E-FBB6-4DAD-9610-821A33E07F6FQ26853728-6CDF2D04-2142-42CE-9E09-57ABFD37C48AQ28385542-0B5F2C46-6CE7-4B03-9072-EBD8D7E9AA59Q28397180-2DE728AD-47BE-4678-8AF7-E05EA5CAE7B0Q28510051-F7F33EE9-953C-4711-82A2-1EAED61E877FQ31139153-097AE3BB-B745-4DB5-8159-083458BB8F66Q33670792-2C03704F-A3F6-4897-BE28-24310FF8D3EFQ34185962-F0E5D198-0032-4C18-AB00-3850AF6FB7DEQ34758981-7E1CEA31-26DA-4C53-B118-8382BFACE962Q35723924-9BAE99C3-BC4B-439C-BDA9-6309885F3816Q35939346-AADFCF9C-4F6C-4A7C-BC99-8BE88532E141Q35982483-558C4DA8-5088-4E3C-9CD3-D41AEC72710EQ36237885-48A98884-169C-4CF4-A9D3-AC761FB8045BQ36262563-31DE27F3-0BE9-434B-A4DC-8359DDC31782Q36817031-AF06ED8B-31C4-4B1B-A57E-731995C6D311Q37240251-CD78DE70-3123-40F4-B53C-BE80F8A7C76DQ38028660-591AF0F5-6E70-4E98-866C-FD279B797D33Q38153378-56AEF27D-DD73-45D6-8682-83A5A7ABBE95Q38160393-37CB3F37-19EE-4A1A-B3BC-599AF48BF846Q40283258-A1034E1D-0638-447C-8BA3-B2D4B09DFFC9Q40387184-52283AC9-A5DF-477C-AA22-0463DB8988A7Q40513576-BD5C11B1-478B-4A5E-B399-EB38B7999F0FQ40548907-54E72ADD-4435-4B52-A3E1-4EA1C16FE2C0Q40625148-6543B4D3-1AEC-4801-9B0C-20B1E9601712Q42247368-32B1AB8B-7D6E-4EDD-914E-FB7E6D66BDB1Q42515890-3E34E4A6-0DD8-491E-B57D-DF3712FDB2ECQ43116571-2909E5C3-B1EF-4283-A9AF-1CCB2BEA7E7EQ44903215-49449155-BB5E-4E1A-99E2-C86458F86D82Q46689122-B8A467E8-28BF-4C05-AF49-4694DF1282E1Q47142479-1B3A92B4-BF1A-4641-9DA7-A6C664FBF38FQ47974257-4D8CF064-877A-41AD-BD9D-28F1FF144BE2Q48049248-9D601042-31C3-4732-A5DB-012FE3B8F886Q49123106-AD9C978E-1C6A-4ABE-B90E-546D1D14A945Q51144818-31E91C6C-FBB6-4FA6-A342-837252681238Q59101620-5BAEC7E2-25BD-47B8-A0AF-419FAE4D2DC6
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
K(+) channels as therapeutic drug targets.
@ast
K(+) channels as therapeutic drug targets.
@en
type
label
K(+) channels as therapeutic drug targets.
@ast
K(+) channels as therapeutic drug targets.
@en
prefLabel
K(+) channels as therapeutic drug targets.
@ast
K(+) channels as therapeutic drug targets.
@en
P1476
K(+) channels as therapeutic drug targets.
@en
P2093
Alan Wickenden
P304
P356
10.1016/S0163-7258(02)00201-2
P577
2002-04-01T00:00:00Z